This document outlines an antibiotic policy for a hospital, with examples focusing on the central nervous system department. It provides guidance on empirical and targeted treatment for various CNS infections like meningitis, encephalitis and neurosyphilis. It also covers surgical chemoprophylaxis recommendations for different surgical site classifications from clean to contaminated. The policy aims to reduce antimicrobial resistance and ensure best practice in antibiotic use.
1. Establish diagnosis and severity of infection, obtain microbiological samples before antibiotics, and document indication and duration of antibiotic therapy.
2. Review patient's response, microbiology results, and antibiotic prescription daily to determine if therapy can be simplified, switched to oral, or stopped.
3. Seek senior clinical review within your team and ensure adequate empirical antibiotic prescription for at least 48 hours before contacting an infection specialist.
This document provides guidance on optimal antibiotic use for common community-acquired infections. It discusses trends in antibiotic prescribing and opportunities to improve prescribing for infections like urinary tract infections (UTIs) and skin infections. The document provides empiric antibiotic guidelines and strategies to support antibiotic decisions for conditions like community-acquired pneumonia and UTIs. It aims to establish best practices for antibiotic use in common community infections.
Guideline for the Empirical Treatment of Infections in Adults Tarek Sallam
This document provides guidelines for the empirical treatment of infections in adults. It outlines considerations for when antibiotics should be prescribed and recommendations for initial antibiotic regimens for common infections including sepsis, central nervous system infections, urinary tract infections, infective endocarditis, and respiratory tract infections. The guidelines recommend broad-spectrum antibiotics be initiated rapidly for sepsis and narrowed based on culture results. It emphasizes the importance of documentation, review, and switching to oral antibiotics when possible.
This document discusses tuberculosis (TB) treatment and prevention. It outlines the different types of TB and standard treatment regimens. First-line drugs like isoniazid, rifampin, pyrazinamide and ethambutol are usually given for two months followed by rifampin and isoniazid for four more months. Directly observed therapy is recommended to ensure treatment compliance. The document also discusses drug side effects, counseling points, BCG vaccination, chemoprophylaxis and multidrug-resistant TB options with diminishing treatment protocols.
The document provides guidelines for antibiotic use in the ICU, including recommendations for empirical antibiotic choice, duration of therapy, and risk factors for multidrug-resistant pathogens. Key points addressed include empirically covering likely organisms like Staphylococcus aureus and Pseudomonas in severe CAP and HAP/VAP. Combination therapy and shorter courses are suggested when possible to reduce antibiotic resistance. Lower respiratory tract cultures should be obtained before but not delay treatment, and help determine if therapy can be stopped for negative cultures.
This document discusses guidelines for the management of febrile neutropenia. It covers topics such as:
1. The "add-on" strategy for persistent fever involving starting with a beta-lactam and adding other antibiotics if needed.
2. Recommendations for antibiotic and antifungal prophylaxis depending on risk factors. Quinolone prophylaxis is generally recommended.
3. Evaluation of the first fever episode involves a thorough history, exam, and blood cultures. Imaging is only recommended if clinically indicated.
4. Initial empiric antibiotic regimens depend on risk of multi-drug resistant bacteria but generally involve a beta-lactam alone or in combination with
Bacille Calmette-Guérin (BCG) is an effective immunotherapy for bladder cancer that produces a local immune response. It is administered by reconstituting the powder with saline and instilling it into the bladder through a catheter. The patient must retain the fluid for 1-2 hours to allow the BCG to activate immune cells and cytokines in the bladder wall and urine. Common side effects include cystitis and flu-like symptoms. More severe complications like BCG sepsis require discontinuing treatment and using antimicrobials. BCG is given as a 6-week induction course followed by 1-3 years of maintenance therapy depending on cancer risk level to prevent recurrence and progression of bladder cancer. Radical cystectomy may
Managing-common-infections-Guidance-for-Primary-Care-Mar-22-v1.0.pdfAllan F Kane
This document provides guidance on the management and treatment of common infections in primary care. It aims to promote the safe, effective and economic use of antibiotics while minimizing antibiotic resistance. It outlines 15 principles of treatment including initiating antibiotics promptly for severe infections, prescribing antibiotics only when there is a clear clinical benefit, and using narrow spectrum antibiotics when possible. It then provides treatment guidelines for various upper and lower respiratory tract infections, urinary tract infections, skin infections and other common infections.
1. Establish diagnosis and severity of infection, obtain microbiological samples before antibiotics, and document indication and duration of antibiotic therapy.
2. Review patient's response, microbiology results, and antibiotic prescription daily to determine if therapy can be simplified, switched to oral, or stopped.
3. Seek senior clinical review within your team and ensure adequate empirical antibiotic prescription for at least 48 hours before contacting an infection specialist.
This document provides guidance on optimal antibiotic use for common community-acquired infections. It discusses trends in antibiotic prescribing and opportunities to improve prescribing for infections like urinary tract infections (UTIs) and skin infections. The document provides empiric antibiotic guidelines and strategies to support antibiotic decisions for conditions like community-acquired pneumonia and UTIs. It aims to establish best practices for antibiotic use in common community infections.
Guideline for the Empirical Treatment of Infections in Adults Tarek Sallam
This document provides guidelines for the empirical treatment of infections in adults. It outlines considerations for when antibiotics should be prescribed and recommendations for initial antibiotic regimens for common infections including sepsis, central nervous system infections, urinary tract infections, infective endocarditis, and respiratory tract infections. The guidelines recommend broad-spectrum antibiotics be initiated rapidly for sepsis and narrowed based on culture results. It emphasizes the importance of documentation, review, and switching to oral antibiotics when possible.
This document discusses tuberculosis (TB) treatment and prevention. It outlines the different types of TB and standard treatment regimens. First-line drugs like isoniazid, rifampin, pyrazinamide and ethambutol are usually given for two months followed by rifampin and isoniazid for four more months. Directly observed therapy is recommended to ensure treatment compliance. The document also discusses drug side effects, counseling points, BCG vaccination, chemoprophylaxis and multidrug-resistant TB options with diminishing treatment protocols.
The document provides guidelines for antibiotic use in the ICU, including recommendations for empirical antibiotic choice, duration of therapy, and risk factors for multidrug-resistant pathogens. Key points addressed include empirically covering likely organisms like Staphylococcus aureus and Pseudomonas in severe CAP and HAP/VAP. Combination therapy and shorter courses are suggested when possible to reduce antibiotic resistance. Lower respiratory tract cultures should be obtained before but not delay treatment, and help determine if therapy can be stopped for negative cultures.
This document discusses guidelines for the management of febrile neutropenia. It covers topics such as:
1. The "add-on" strategy for persistent fever involving starting with a beta-lactam and adding other antibiotics if needed.
2. Recommendations for antibiotic and antifungal prophylaxis depending on risk factors. Quinolone prophylaxis is generally recommended.
3. Evaluation of the first fever episode involves a thorough history, exam, and blood cultures. Imaging is only recommended if clinically indicated.
4. Initial empiric antibiotic regimens depend on risk of multi-drug resistant bacteria but generally involve a beta-lactam alone or in combination with
Bacille Calmette-Guérin (BCG) is an effective immunotherapy for bladder cancer that produces a local immune response. It is administered by reconstituting the powder with saline and instilling it into the bladder through a catheter. The patient must retain the fluid for 1-2 hours to allow the BCG to activate immune cells and cytokines in the bladder wall and urine. Common side effects include cystitis and flu-like symptoms. More severe complications like BCG sepsis require discontinuing treatment and using antimicrobials. BCG is given as a 6-week induction course followed by 1-3 years of maintenance therapy depending on cancer risk level to prevent recurrence and progression of bladder cancer. Radical cystectomy may
Managing-common-infections-Guidance-for-Primary-Care-Mar-22-v1.0.pdfAllan F Kane
This document provides guidance on the management and treatment of common infections in primary care. It aims to promote the safe, effective and economic use of antibiotics while minimizing antibiotic resistance. It outlines 15 principles of treatment including initiating antibiotics promptly for severe infections, prescribing antibiotics only when there is a clear clinical benefit, and using narrow spectrum antibiotics when possible. It then provides treatment guidelines for various upper and lower respiratory tract infections, urinary tract infections, skin infections and other common infections.
1) Rational use of antibiotics is important to avoid adverse effects, antibiotic resistance and increased healthcare costs. Antibiotics should only be used for bacterial infections and are not needed for most viral infections.
2) In selecting an antibiotic, the aetiological agent, patient factors, pharmacokinetic properties of the drug, and efficacy of therapy should be considered. Antibiotics must achieve effective concentrations at the site of infection.
3) Guidelines provide recommendations for common infections, but clinical judgement is also needed. Empiric therapy should be modified based on culture results and the patient's response.
This document discusses various therapeutics used in dentistry, focusing on antibiotics. It defines key terms related to antimicrobial drugs and provides an overview of common antibiotics used, including beta-lactams, aminoglycosides, glycopeptides, tetracyclines, macrolides, metronidazole, quinolones, and antitubercular drugs. It also covers indications for antibiotic use, treatment of infections, prophylactic use, routes of administration, treatment failure, antifungals, and antivirals.
This document provides guidelines for antibiotic treatment of common infections in general practice. It lists respiratory infections, ear, nose and throat infections, and gastrointestinal and genitourinary infections. For each condition, it summarizes the management, common pathogens, and first-choice and alternative antibiotic treatments. The guidelines aim to promote prudent antibiotic use and recommend first choosing effective first-line antibiotics, reserving broad-spectrum antibiotics only for indicated conditions.
Antibioitcs guide choice for common infection (doc toon.page)abdullahsharaf55
1. The document provides guidelines for choosing appropriate antibiotic treatment for various common infections seen in general practice.
2. It emphasizes using first-line antibiotics first, reserving broad spectrum antibiotics only for indicated conditions, and considering local resistance patterns when selecting treatment.
3. The guidelines provide recommendations for first-choice and alternative antibiotic treatments for various respiratory, ear/nose/throat, eye, and other infections, noting principles like only prescribing antibiotics for bacterial infections when symptoms are significant.
Antibioitcs choices for common infections (2013 edition)Ahmad Ali
Antibiotic choices for common infections provides guidelines for treating common infections in primary care settings. It recommends first-line antibiotic choices for conditions like respiratory infections, ear infections, eye infections, and more. Prudent antibiotic use is important due to increasing antimicrobial resistance. Symptoms, severity, and risk of complications should guide antibiotic decisions. Broad-spectrum antibiotics should be reserved for specific conditions.
Antibiotic choices for common infections provides guidelines for treating common infections in primary care settings. It recommends first-line antibiotic choices for conditions like respiratory infections, ear infections, eye infections, and more. Prudent antibiotic use is important due to increasing antimicrobial resistance. Symptoms should be significant before prescribing antibiotics for likely bacterial infections. Broad-spectrum antibiotics should be reserved for specific conditions. Individual circumstances may require flexibility from the guidelines.
The document summarizes recent updates to national guidelines for diagnosis and management of pediatric tuberculosis (TB) in India. Key points include:
- Bacteriological evidence is preferred for diagnosis but alternative specimens can be used if needed. The optimal strength of the tuberculin skin test was updated.
- Diagnostic algorithms were provided for pulmonary and lymph node TB. Daily dosing recommendations for anti-TB drugs were included.
- New case definitions and only two treatment categories (new cases and previously treated) are recommended. Preventive therapy guidelines were also updated.
This document provides guidelines for the treatment of COVID-19 and its complications. It defines suspected, probable and confirmed COVID-19 cases. It describes the clinical categorization of cases and recommendations for investigations and medications like remdesivir, tocilizumab, baricitinib, monoclonal antibodies, and guidelines for multisystem inflammatory syndrome in children and adults. It also discusses COVID-associated mucormycosis and its treatment involving antifungal therapy, surgical debridement, and monitoring for response.
Rational use of antibiotics by M. Jagadeesh, Creative Educational Society's C...Dr. Jagadeesh Mangamoori
This document provides guidelines for the rational use of antibiotics, including:
1) Antibiotics should only be used for bacterial infections and are not always necessary even when bacteria are present.
2) Several factors must be considered when selecting an antibiotic such as the causative agent, the patient, and the antibiotic's properties.
3) Antibiotic treatment should be reviewed early and adjusted if needed based on the patient's response. Guidelines are also provided for common infections.
This document provides an overview of tuberculosis (TB) management in India, including:
1) TB burden statistics for India and trends in multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB cases.
2) Guidelines for treatment of drug-sensitive TB, MDR-TB, and XDR-TB including different regimens and drugs.
3) Special considerations for managing TB in vulnerable groups like children, pregnant women, and those with comorbidities.
4) India's adoption of WHO's End TB Strategy to cut TB deaths and cases by 2035.
This document discusses antibiotics, including their definitions, mechanisms of action, contraindications, drug interactions, and a study on antibiotic dispensing in Egyptian community pharmacies. The study aimed to describe antibiotic use patterns in Egypt. It found that the majority of antibiotics were dispensed without being checked by a pharmacist. Common reasons for dispensing included respiratory and urinary tract infections. Penicillins and cephalosporins were most commonly dispensed both with and without prescriptions. The high use and misuse of antibiotics in Egypt risks increasing antibiotic resistance.
The document discusses various topics related to antibiotics including their history, definitions, classifications, mechanisms of action, and guidelines for use. Some key points:
- Antibiotics are drugs produced by microorganisms that inhibit or destroy other microorganisms. They can be naturally occurring, semisynthetic, or synthetic.
- Major classifications include based on chemical structure, mechanism of action, type of organism targeted, and spectrum of activity.
- Penicillin was the first antibiotic to be used clinically in 1941. Extended-spectrum penicillins like ampicillin are broad-spectrum and cover both gram-positive and gram-negative bacteria commonly causing dental infections.
- Guidelines emphasize accurate diagnosis, appropriate antibiotic selection
This document provides guidelines for rational antibiotic therapy. It discusses the importance of rational antibiotic use to better care for patients, combat antimicrobial resistance, and reduce costs. It outlines strategies for choosing the appropriate antibiotic based on diagnosis, likely pathogens, sensitivity patterns, and patient factors. Specific antibiotic recommendations are provided for common bacterial infections affecting various body systems like skin, ENT, respiratory, GI, urinary, CNS, and cardiovascular. It also discusses approaches for antibiotic prophylaxis and strategies to prevent antibiotic resistance.
This document defines key terms related to antimicrobial drugs and provides guidance on their appropriate use. It discusses:
1. Common types of antimicrobial drugs including antibacterial, antiviral, antifungal, and antiparasitic.
2. Characteristics of broad and narrow spectrum antibacterials.
3. Mechanisms of action for killing or inhibiting bacterial growth.
4. Examples of common antibiotics and their indications.
5. Factors to consider when selecting an antibiotic for odontogenic infections.
This document discusses antibiotics used in oral and maxillofacial surgery. It begins by defining antibiotics and chemotherapy. It then covers the history of antibiotic discovery and classification of antibiotics based on type of organism affected and mechanism of action. The document discusses sources of antibiotics and principles of antibiotic therapy selection, including determining infection severity, choosing an appropriate antibiotic based on the causative organism, and ensuring proper administration. It provides examples of empirical antibiotic treatment for different stages of infection and guidelines for dosing antibiotics based on patient factors.
This document discusses antimycobacterial drugs used to treat tuberculosis and other mycobacterial infections. It provides information on various first-line drugs including isoniazid, rifampin, pyrazinamide, ethambutol, and streptomycin. It notes that combinations of two or more drugs are required to treat mycobacterial infections due to slow growth and potential drug resistance. Treatment must be prolonged, typically for months to years, to eliminate both actively dividing and dormant bacteria. Second-line drugs are discussed for treatment of multi-drug resistant infections. Worldwide tuberculosis statistics and drug regimens are also summarized.
This document discusses antibiotic therapy for musculoskeletal infections. It begins by outlining the learning objectives which are to discuss musculoskeletal infections, antibiotic recommendations, periprosthetic infections, and prophylactic antibiotic therapy. It then covers topics like the types of musculoskeletal infections, factors to consider when selecting antibiotics, common routes of administration, organisms associated with different infections, and treatment guidelines. It provides treatment recommendations for various pathogens. It concludes by listing some commonly used antibiotics for musculoskeletal infections and their characteristics.
1. The document outlines India's national policy for malaria control, which focuses on early detection and treatment of cases in communities through trained health workers. It also describes vector control strategies like indoor residual spraying and larviciding.
2. The treatment guidelines recommend chloroquine as first-line treatment, switching to ACT for resistant cases. Guidelines for treating uncomplicated and severe malaria are provided, along with dosages for different antimalarial drugs.
3. The policy emphasizes active community participation in control efforts and an integrated approach combining vector control with case management.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
1) Rational use of antibiotics is important to avoid adverse effects, antibiotic resistance and increased healthcare costs. Antibiotics should only be used for bacterial infections and are not needed for most viral infections.
2) In selecting an antibiotic, the aetiological agent, patient factors, pharmacokinetic properties of the drug, and efficacy of therapy should be considered. Antibiotics must achieve effective concentrations at the site of infection.
3) Guidelines provide recommendations for common infections, but clinical judgement is also needed. Empiric therapy should be modified based on culture results and the patient's response.
This document discusses various therapeutics used in dentistry, focusing on antibiotics. It defines key terms related to antimicrobial drugs and provides an overview of common antibiotics used, including beta-lactams, aminoglycosides, glycopeptides, tetracyclines, macrolides, metronidazole, quinolones, and antitubercular drugs. It also covers indications for antibiotic use, treatment of infections, prophylactic use, routes of administration, treatment failure, antifungals, and antivirals.
This document provides guidelines for antibiotic treatment of common infections in general practice. It lists respiratory infections, ear, nose and throat infections, and gastrointestinal and genitourinary infections. For each condition, it summarizes the management, common pathogens, and first-choice and alternative antibiotic treatments. The guidelines aim to promote prudent antibiotic use and recommend first choosing effective first-line antibiotics, reserving broad-spectrum antibiotics only for indicated conditions.
Antibioitcs guide choice for common infection (doc toon.page)abdullahsharaf55
1. The document provides guidelines for choosing appropriate antibiotic treatment for various common infections seen in general practice.
2. It emphasizes using first-line antibiotics first, reserving broad spectrum antibiotics only for indicated conditions, and considering local resistance patterns when selecting treatment.
3. The guidelines provide recommendations for first-choice and alternative antibiotic treatments for various respiratory, ear/nose/throat, eye, and other infections, noting principles like only prescribing antibiotics for bacterial infections when symptoms are significant.
Antibioitcs choices for common infections (2013 edition)Ahmad Ali
Antibiotic choices for common infections provides guidelines for treating common infections in primary care settings. It recommends first-line antibiotic choices for conditions like respiratory infections, ear infections, eye infections, and more. Prudent antibiotic use is important due to increasing antimicrobial resistance. Symptoms, severity, and risk of complications should guide antibiotic decisions. Broad-spectrum antibiotics should be reserved for specific conditions.
Antibiotic choices for common infections provides guidelines for treating common infections in primary care settings. It recommends first-line antibiotic choices for conditions like respiratory infections, ear infections, eye infections, and more. Prudent antibiotic use is important due to increasing antimicrobial resistance. Symptoms should be significant before prescribing antibiotics for likely bacterial infections. Broad-spectrum antibiotics should be reserved for specific conditions. Individual circumstances may require flexibility from the guidelines.
The document summarizes recent updates to national guidelines for diagnosis and management of pediatric tuberculosis (TB) in India. Key points include:
- Bacteriological evidence is preferred for diagnosis but alternative specimens can be used if needed. The optimal strength of the tuberculin skin test was updated.
- Diagnostic algorithms were provided for pulmonary and lymph node TB. Daily dosing recommendations for anti-TB drugs were included.
- New case definitions and only two treatment categories (new cases and previously treated) are recommended. Preventive therapy guidelines were also updated.
This document provides guidelines for the treatment of COVID-19 and its complications. It defines suspected, probable and confirmed COVID-19 cases. It describes the clinical categorization of cases and recommendations for investigations and medications like remdesivir, tocilizumab, baricitinib, monoclonal antibodies, and guidelines for multisystem inflammatory syndrome in children and adults. It also discusses COVID-associated mucormycosis and its treatment involving antifungal therapy, surgical debridement, and monitoring for response.
Rational use of antibiotics by M. Jagadeesh, Creative Educational Society's C...Dr. Jagadeesh Mangamoori
This document provides guidelines for the rational use of antibiotics, including:
1) Antibiotics should only be used for bacterial infections and are not always necessary even when bacteria are present.
2) Several factors must be considered when selecting an antibiotic such as the causative agent, the patient, and the antibiotic's properties.
3) Antibiotic treatment should be reviewed early and adjusted if needed based on the patient's response. Guidelines are also provided for common infections.
This document provides an overview of tuberculosis (TB) management in India, including:
1) TB burden statistics for India and trends in multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB cases.
2) Guidelines for treatment of drug-sensitive TB, MDR-TB, and XDR-TB including different regimens and drugs.
3) Special considerations for managing TB in vulnerable groups like children, pregnant women, and those with comorbidities.
4) India's adoption of WHO's End TB Strategy to cut TB deaths and cases by 2035.
This document discusses antibiotics, including their definitions, mechanisms of action, contraindications, drug interactions, and a study on antibiotic dispensing in Egyptian community pharmacies. The study aimed to describe antibiotic use patterns in Egypt. It found that the majority of antibiotics were dispensed without being checked by a pharmacist. Common reasons for dispensing included respiratory and urinary tract infections. Penicillins and cephalosporins were most commonly dispensed both with and without prescriptions. The high use and misuse of antibiotics in Egypt risks increasing antibiotic resistance.
The document discusses various topics related to antibiotics including their history, definitions, classifications, mechanisms of action, and guidelines for use. Some key points:
- Antibiotics are drugs produced by microorganisms that inhibit or destroy other microorganisms. They can be naturally occurring, semisynthetic, or synthetic.
- Major classifications include based on chemical structure, mechanism of action, type of organism targeted, and spectrum of activity.
- Penicillin was the first antibiotic to be used clinically in 1941. Extended-spectrum penicillins like ampicillin are broad-spectrum and cover both gram-positive and gram-negative bacteria commonly causing dental infections.
- Guidelines emphasize accurate diagnosis, appropriate antibiotic selection
This document provides guidelines for rational antibiotic therapy. It discusses the importance of rational antibiotic use to better care for patients, combat antimicrobial resistance, and reduce costs. It outlines strategies for choosing the appropriate antibiotic based on diagnosis, likely pathogens, sensitivity patterns, and patient factors. Specific antibiotic recommendations are provided for common bacterial infections affecting various body systems like skin, ENT, respiratory, GI, urinary, CNS, and cardiovascular. It also discusses approaches for antibiotic prophylaxis and strategies to prevent antibiotic resistance.
This document defines key terms related to antimicrobial drugs and provides guidance on their appropriate use. It discusses:
1. Common types of antimicrobial drugs including antibacterial, antiviral, antifungal, and antiparasitic.
2. Characteristics of broad and narrow spectrum antibacterials.
3. Mechanisms of action for killing or inhibiting bacterial growth.
4. Examples of common antibiotics and their indications.
5. Factors to consider when selecting an antibiotic for odontogenic infections.
This document discusses antibiotics used in oral and maxillofacial surgery. It begins by defining antibiotics and chemotherapy. It then covers the history of antibiotic discovery and classification of antibiotics based on type of organism affected and mechanism of action. The document discusses sources of antibiotics and principles of antibiotic therapy selection, including determining infection severity, choosing an appropriate antibiotic based on the causative organism, and ensuring proper administration. It provides examples of empirical antibiotic treatment for different stages of infection and guidelines for dosing antibiotics based on patient factors.
This document discusses antimycobacterial drugs used to treat tuberculosis and other mycobacterial infections. It provides information on various first-line drugs including isoniazid, rifampin, pyrazinamide, ethambutol, and streptomycin. It notes that combinations of two or more drugs are required to treat mycobacterial infections due to slow growth and potential drug resistance. Treatment must be prolonged, typically for months to years, to eliminate both actively dividing and dormant bacteria. Second-line drugs are discussed for treatment of multi-drug resistant infections. Worldwide tuberculosis statistics and drug regimens are also summarized.
This document discusses antibiotic therapy for musculoskeletal infections. It begins by outlining the learning objectives which are to discuss musculoskeletal infections, antibiotic recommendations, periprosthetic infections, and prophylactic antibiotic therapy. It then covers topics like the types of musculoskeletal infections, factors to consider when selecting antibiotics, common routes of administration, organisms associated with different infections, and treatment guidelines. It provides treatment recommendations for various pathogens. It concludes by listing some commonly used antibiotics for musculoskeletal infections and their characteristics.
1. The document outlines India's national policy for malaria control, which focuses on early detection and treatment of cases in communities through trained health workers. It also describes vector control strategies like indoor residual spraying and larviciding.
2. The treatment guidelines recommend chloroquine as first-line treatment, switching to ACT for resistant cases. Guidelines for treating uncomplicated and severe malaria are provided, along with dosages for different antimalarial drugs.
3. The policy emphasizes active community participation in control efforts and an integrated approach combining vector control with case management.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptxHolistified Wellness
We’re talking about Vedic Meditation, a form of meditation that has been around for at least 5,000 years. Back then, the people who lived in the Indus Valley, now known as India and Pakistan, practised meditation as a fundamental part of daily life. This knowledge that has given us yoga and Ayurveda, was known as Veda, hence the name Vedic. And though there are some written records, the practice has been passed down verbally from generation to generation.
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
share - Lions, tigers, AI and health misinformation, oh my!.pptxTina Purnat
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
6. • Avoid treating viral syndromes with antibiotics
• choose the right antibiotic
• Proper prophylaxis policy
• Pay attention to dose and duration
7.
8.
9. Aim of Antibiotic Policy
Reduce the Antimicrobial resistance.
Practice best efforts, these resistance strains do not spill into critically
ill patients in the Hospital.
To prevent spill into Society, as they present as community associated
infections.
10. Objectives of Antibiotic Policy
Antibiotics should not be used if unnecessary.
Policy emphasizes, avoiding the use of powerful Antibiotics in the Initial
treatments.
We should create awareness that we are sparing the powerful Broad
spectrum Drugs for later treatment
Patient saves Money
Doctors save Lives
11. Hospital Antibiotic Committee
*Clinicians / Microbiologists / Pharmacists and Nurses do take part.
* Policies are framed on demands of the Clinical areas, depending on recent
Infection surveillance data contributed from Microbiology Departments.
- The Pharmacist who will report back to the Antibiotic Committee at each
meeting on drug utilisation and cost.
- The Microbiologist who will report on antibiotic susceptibility patterns of
bacteria isolated from major infections.
- Clinical doctors and nurses responsible for direct patient care who provide a
link between clinical practice and the Antibiotic Committee
- Manger(s) who will ensure the resources are available for implementation of the antibiotic
policy.
- Reciprocal Membership between the Infection Control Committee and the Drugs Committee
should be ensured.
12. The policy should
contain guidance on antibiotic prophylaxis (e.g. in surgery with details
of timing, route, dosage and frequency)
contain guidance on the choice of antibiotics for empirical and targeted
therapy of major infections
indicate first and second line therapy for common infections
13. Sample collection
Proper specimen collection is combined responsibility of Clinical and
Microbiological Departments.
Continuous training of junior staff on sample collection, and is most
neglected necessity
A good clinical history is greatly helpful in differentiating community
acquired infections from hospital acquired infections.
14. Staff Education on Antibiotic Policy
Staff education is most Important principle in success
Induction training for new staff
Continuing Medical Education to both Junior and Senior practioners.
Include nursing staff, pharmacists for the success of the Program
18. Comments
Suggested Treatment
Infection/ Condition & Likely organism
Antibiotic treatment must be
started immediately, regardless of
any investigations undertaken…….. If
no organism isolated and patient is
responding, continue antibiotics for
14 days
Alternative
If no clinical
response after 3
days
of antibiotics:
Meropenem 2.0gm
IV q8h.
Dexamethasone
10mg IV q6h is
recommended to
be administered
15 to 20 minutes
before or at the
time of first dose
of antibiotics, for
up to 4 days or
until there is no
evidence of
pneumococcal
meningitis.
Preferred
Empirical
treatment on
admission:
Ceftriaxone 2gm IV
q12h.
OR
Cefotaxime 2-4gm
IV q8h
Meningitis (acute)
Common organisms:
Streptococcus pneumoniae
Neisseria meningitidis
Haemophilus influenzae
Other organisms:
Gram negative rods
Leptospirosis
Scrub typhus
Melioidosis
Mycoplasma pneumoniae
19. Comments
Suggested Treatment
Infection/ Condition & Likely organism
Alternative
Meropenem 2.0gm
IV q8h
OR
Cefepime 2gm IV
q12h.
If organism is
susceptible:
Chloramphenicol
1gm IV q6h for 14
days.
Preferred
Ceftriaxone 2gm IV
q12h
OR
Cefotaxime 2-4gm
IV q8h
OR
Ceftazidime 2gm
IV q8h.
Duration of
treatment: 10-14
days.
(very ill patients
may require
treatment for 21
days.)
Causative organism isolated:
Haemophilus influenzae
(Gram-ve bacilli)
20. Comments
Suggested Treatment
Infection/ Condition & Likely organism
For penicillin
resistant strains
Vancomycin 1gm
IV q12h
PLUS
Ceftriaxone 2gm
IV q12h
Relatively-resistant
strains
Ceftriaxone 2gm IV
q12h
Or
Cefotaxime 2-4gm IV
q8h
OR
(either)
Cefotaxime 2-4gm IV
q8h
1. Meropenem 2.0gm IV
q8h
for 10-14 days
2. Cefepime 2gm IV
q12h.
3.Fluroquinolone PLUS
Rifampicin
Duration of treatment:
10-14
days. (very ill patients
may require treatment
for 21 days.)
Penicillin-
sensitive
strains
Benzylpenicill
in 4MU IV q4-
6h for
10-14 days
Causative organism isolated:
Streptococcus pneumoniae
(Gram +ve cocci)
21. Comments
Suggested Treatment
Infection/ Condition & Likely organism
Close contacts are defined as those
individuals who have had contact
with oropharyngeal secretions
either through kissing or by sharing
toys, beverages, or cigarettes
Alternative
Chloramphenicol
1gm IV q6h.
Ceftriaxone 250mg
IM as single
dose (especially in
pregnancy);
OR
Azithromycin
500mg PO as
single
dose.
Preferred
Ceftriaxone 2gm IV
q12 h
OR
Cefotaxime 2-4gm
IV q8h
OR
Ceftazidime 2gm
IV q8h.
Ciprofloxacin
500mg PO as
single
dose;
OR
Rifampicin 600mg
PO q12h for 2
days (4 doses) [not
recommended
in pregnant
women].
Causative organism isolated:
Neisseria meningitidis
(Gram –ve cocci)
Prophylaxis for household and
close contacts for meningococcal
meningitis
22. Comments
Suggested Treatment
Infection/ Condition & Likely organism
Ceftriaxone 2gm IV
q12 h
OR
Cefotaxime 2-4gm
IV q8h.
Duration of
treatment: 10-14
days.
(Very ill patients
may require
treatment for 21
days.)
Causative organism isolated:
Gram-negative
Enterobacteriaceae
23. Comments
Suggested Treatment
Infection/ Condition & Likely organism
Acyclovir 500mg IV
q8h for 14-21
days.
(Duration of
treatment may be
extended to 21 days
in severe cases
or in
immunosuppressed
patients.
:
Viral encephalitis
Herpes simplex
Herpes zoster
24. Comments
Suggested Treatment
Infection/ Condition & Likely organism
Alternative
Valganciclovir
900mg PO q12h
Valganciclovir PO
900mg PO q24h
for 6 months
depending on
severity
of disease, time to
response and
end organ
involvement.
Preferred
Ganciclovir 5mg/kg
IV q12h for 21
Days
Ganciclovir 5mg/kg
IV q24h for 6
months depending
on severity of
disease, time to
response and end
organ involvement.
May switch to
oral.
Causative organism isolated:
Cytomegalovirus (CMV)
In immunocompromised patients
Induction phase:
Maintenance phase:
25. Comments
Suggested Treatment
Infection/ Condition & Likely organism
Intensive 2 months S/EHRZ and 10
months HR.
• Isoniazid (H) 5 (4-6) mg/kg/24h
PO
(max: 300 mg/day)
PLUS
• Rifampicin (R) 10 (8-12)
mg/kg/24h PO
(max: 600 mg/day)
PLUS
• Pyrazinamide (Z) 25 (20-30)
mg/kg/24h PO (max: 2000
mg/day)
PLUS
• Streptomycin (S) 15 (12-18)
mg/kg/24h IM (max: 1000adults.
mg/day)
?
Meningitis (chronic)
Tuberculous meningitis
(Mycobacterium tuberculosis)
26. Comments
Suggested Treatment
Infection/ Condition & Likely
organism
End point of treatment: till at least
total of 1.5-2.0gm of Amphotericin
B given and CSF shows clearance of
fungus by 2 negative C&S one
month apart, and CSF Cryptococcal
antigen titre becomes negative or
at least 1:2 or shows a fourfold
decrease.
Liposomal Amphotericin may be
used in cases of severe toxicity to
Amphotericin B
e.g. Abelcet 3-5mg/kg/day
Alternative
Fluconazole 400mg
IV q24h
initially and then
200-400mg IV
q24h for 6-8 weeks.
Fluconazole
“consolidation”
therapy may be
continued for as
long as 6-12 months,
depending on
the clinical status of
the patient.
Preferred
Amphotericin B 0.7-
1.0mg/kg/24h
IV
PLUS
5-Flucytosine 100-150mg/kg/24h
PO q6h for 2-4 weeks.
Or
Fluconazole 400mg PO q24h
.(If Fluconazole is not tolerated:
Itraconazole 200mg PO q12h)
Fluconazole 400-800mg PO q24h
for 8 weeks.
Cryptococcal meningitis
Cryptococcus neoformans
Induction Therapy:
Consolidation Therapy:
27. Comments
Suggested Treatment
Infection/ Condition & Likely organism
• Repeat CSF examinations every 6
months. Consider retreatment if cell
count is not decreased in 6 months or
CSF is not entirely normal in 2 years
• All patients with neurosyphilis should be
considered for corticosteroid cover
at the start of the therapy to prevent
the Jarisch-Herxheimer reaction
(Prednisolone 10-20mg PO q8h for
3 days commencing one day prior to
syphilis treatment)
Ceftriaxone 2gm
IM (with Lidocaine
as
diluent) or IV (with
water for injection
as
diluent) for 10-14
days (if no
anaphylaxis
to penicillin)
Aqueous crystalline
penicillin
G, 18-4MU/day,
administered
3 - 4 MU q4h IV for
14 days
OR
Procaine Penicillin
2.4MU IM
q24h
PLUS
Probenecid 500mg
PO q6h for
14 days
Neurosyphilis
28. SURGICAL CHEMOPROPHYLAXIS
It is the use of antibiotics to prevent infections at the surgical site.
It should be considered when there is significant risk of post-operative infection or where post-operative infection
would have severe consequences.
Ideally, the prophylaxis when given intravenously should be given as soon as the patient is stabilized after induction.
Usually a single dose is sufficient. Asecond dose may be required in the following situations:
a. delay in start of surgery
b. in prolonged operations when the time is more than half of the usual dosing interval of the antibiotic
Pre-operative dose timing: The optimal time for administration of preoperative doses is within 60 minutes before
surgical incision.…Some agents, such as Clindamycin, Fluoroquinolones, Gentamicin, Metronidazole and Vancomycin,
require administration over one to two hours; therefore, the administration of these agents should begin within 120
minutes before surgical incision
Giving more than 1 or 2 doses postoperatively is generally not advised. The practice of continuing prophylactic
antibiotics until surgical drains have been removed is NOT RECOMMENDED.
29. Comments
Suggested Treatment
Infection/ Condition & Likely organism
Ceftriaxone 2gm IV
single dose one
hour prior to skin
incision
Ceftriaxone 2gm IV
one hour prior to
skin incision,
followed by repeat
dose 1gm IV q12h
till completion of
Surgery
β-Lactam Allergy:
Clindamycin 900mg IV
MRSA colonisation:
Vancomycin 15mg/kg IV
Cefuroxime 1.5gm
IV single dose one
hour prior to skin
incision
Cefuroxime 1.5gm
IV one hour prior
to skin incision,
followed by repeat
dose 750mg IV q8h
till completion of
surgery
Clean (Craniotomy, burrhole for
clean pathology)
< 4 hours
> 4 hours
30. Comments
Suggested Treatment
Infection/ Condition & Likely organism
Ceftriaxone 2gm IV
one hour prior to
skin incision.
β-Lactam Allergy:
Clindamycin 900mg IV
MRSA colonisation:
Vancomycin 15mg/kg IV
Cefuroxime 1.5gm
IV single dose one
hour prior to skin
incision
Clean + Implant (CSF diversion
procedures e.g. Shunt, EVD,
omaya, DBS, Titanium/acrylic
craniplasty, artificial dura used)
Ceftriaxone 2gm IV
single dose one
hour prior to skin
incision followed
by three repeated
doses of 1gm IV
q12h.
β-Lactam Allergy:
Clindamycin 900mg IV
MRSA colonisation:
Vancomycin 15mg/kg IV
Cefuroxime 1.5gm
IV single dose one
hour prior to skin
incision, followed
by three repeated
doses of 750mg IV
q8h
Clean contaminated
(Transphenoidal, Acosutic
neuroma, involving air sinuses)
31. Comments
Suggested Treatment
Infection/ Condition & Likely
organism
Ceftriaxone 2gmIV q12h
PLUS/MINUS
Metronidazole 500mg IV q8h for 72
hours.
β-Lactam Allergy:
Clindamycin 900mg IV
MRSA colonisation:
Vancomycin 15mg/kg IV
Cefuroxime 1.5gm IV q8h
PLUS/MINUS
Metronidazole 500mg IV q8h
for 72
hours
Contaminated (Skull fracture,
previous surgery, lacerated scalp)
Meropenem 2gm IV q8h
PLUS/MINUS
Metronidazole 500mg IV q8h
MRSA colonization:
Vancomycin 20mg/kg IV
Pseudomonas infection:
Cefepime 2g IV q8h
OR
Ceftazidime 2g IV q8h
Ceftriaxone 2gm IV q12h
PLUS/MINUS
Metronidazole 500mg IV q8h
For 6-8 weeks depending on
response.
Dirty (brain abscess, subdural
empyema, ventriculitis)
33. Comments
Suggested Treatment
Infection/ Condition & Likely organism
Prophylaxis for all household
contacts if there are unimmunised
or partially immunised children < 4
years old.
If suspected
penicillin-resistant
Strep pneumonia:
Cefotaxime
50mg/kg IV q4-6h
OR
Ceftriaxone for 50-
75mg/kg IV
q12-24h for 10-14
days
PLUS
Vancomycin
15mg/kg IV q6h
Cefotaxime
50mg/kg IV q4-
6h
OR
Ceftriaxone 50-
75mg/kg IV q12-
24h for 10-14
days.
If < 3 month-old,
ADD:
Benzylpenicillin
50mg/kg IVq4-6h
OR
Ampicillin
50mg/kg IV q4-
6h
Meningitis
empirical treatment
34. Comments
Suggested Treatment
Infection/ Condition & Likely organism
Chloramphenicol 40mg/kg
IV stat
then 25mg/kg q6h for 10-
14 days;
OR
Cefepime 50mg/kg IV q8h
for 10-
14 days
Cefotaxime
50mg/kg IV q4-6h
OR
Ceftriaxone 50-
75mg/kg IV q12-
24h for 10-14
days..)
Causative organism isolated:
Haemophilus influenza
Strepcoccus pneumoniae
Prophylaxis for all household
contacts and Health Care
Workers
involved in intubation and
suctioning of airway
Cefotaxime 50mg/kg IV q4-
6h
OR
Ceftriaxone 50-75mg/kg IV
q12-
24h for 7 days.
OR
Chloramphenicol 40mg/kg
stat
Benzylpenicillin
50mg/kg IV q4-6h
for 7 days
Causative organism isolated:
Neisseria meningitidis
35. Comments
Suggested Treatment
Infection/ Condition & Likely organism
Amphotericin B
1.0mg/kg/24h IV
PLUS/ MINUS
5-Flucytosine 400-
1200mg/m2
(max 2gm) PO in
q6h for 2-4
weeks.
Fluconazole 10-
12mg/kg/24h PO
in q12h for 8
weeks.
Causative organism isolated:
Cryptococcal meningitis
Cryptococcus neoformans
Induction Therapy:
Consolidation Therapy:
Duration: for 14-21 days.
Acyclovir:
< 12 weeks old:
20mg/kg IV q8h
12 weeks-12 years
old: 500mg/m2
IV q8h
If > 12 years olds:
10mg/kg IV q8h
HerpesSimplexEncephalitis
36. Comments
Suggested Treatment
Infection/ Condition & Likely organism
Surgical drainage may be indicated
if appropriate.
Duration 6-8 weeks, depending on
response as seen from
neuroimaging.
If secondary to
trauma:
ADD
Cloxacillin 25-
50mg/kg IV q4-6h.
Cefotaxime
50mg/kg IV q4-6h
OR
Ceftriaxone 50-
75mg/kg IV q12-
24h
PLUS
Metronidazole
15mg/kg IV stat
then 7.5mg/kg IV
q8h.
BrainAbscess